SPDR® S&P Biotech ETF (XBI)

Add to Watchlists
Create an Alert
70.15 +0.50  +0.72% NYSE Arca May 24, 16:59 Delayed 2m USD
View Full Chart
XBI Price Chart

XBI Key Stats

Net Asset Value 69.62
Discount or Premium to NAV 0.04%
Turnover Ratio 75.00

XBI Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 2.46% 2.72% 60
3M 3.77% 3.08% 50
6M 6.01% 10.31% 75
1Y 32.72% 12.74% 4
3Y 19.26% 9.71% 3
5Y 21.99% 17.49% 1
As of May 23, 2017
Returns for periods of 1 year and above are annualized.

XBI Asset Allocation

Type % Net % Long % Short
Cash 0.00 0.00 0.00
Stock 99.93% 99.93% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.07% 0.07% 0.00
As of May 22, 2017

XBI Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00
Greater Europe 0.00
United Kingdom 0.00
Europe Developed 0.00
Europe Emerging 0.00
Africa/Middle East 0.00
Greater Asia 0.00
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00
As of May 19, 2017
Region breakdown data is calculated by using the long position holdings of the portfolio.

XBI Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 100.0%
Industrials 0.00
Real Estate 0.00
Technology 0.00
Utilities 0.00
As of May 22, 2017

XBI Stock Market Capitalization

Giant 6.78%
Large 14.82%
Medium 27.01%
Small 34.48%
Micro 16.91%
As of May 22, 2017

XBI Stock Style Exposure

Large Cap Value 4.59%
Large Cap Blend 2.20%
Large Cap Growth 15.89%
Mid Cap Value 0.00
Mid Cap Blend 2.65%
Mid Cap Growth 25.71%
Small Cap Value 0.13%
Small Cap Blend 6.25%
Small Cap Growth 42.58%
As of May 22, 2017
View More Holdings

XBI Top 10 Holdings

Symbol Name % Weight Price % Chg
VRTX Vertex Pharmaceuticals Inc 3.09% 117.90 +1.12%
REGN Regeneron Pharmaceuticals Inc 2.90% 462.93 +0.34%
EXAS Exact Sciences Corp 2.85% 32.96 +3.32%
ALNY Alnylam Pharmaceuticals Inc 2.82% 69.92 -6.61%
IONS Ionis Pharmaceuticals Inc 2.61% 46.49 +2.99%
NBIX Neurocrine Biosciences Inc 2.58% 48.91 -8.63%
BIVV Bioverativ Inc 2.52% 54.32 +3.47%
SRPT Sarepta Therapeutics Inc 2.45% 32.46 +0.59%
ABBV AbbVie Inc 2.43% 65.93 +0.14%
SGEN Seattle Genetics Inc 2.39% 67.45 +1.17%
As of May 22, 2017
Advertisement

XBI Ratings

Fiduciary Score Upgrade

XBI One Page Reports

XBI Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Biotechnology Select Industry TR USD
100.0%

XBI Manager Info

Name Tenure
Karl Schneider 2.50 yrs
Michael Feehily 5.50 yrs
Raymond Donofrio 0.32 yrs

XBI Net Fund Flows

1M 93.75M
3M 218.63M
6M 210.73M
YTD 228.51M
1Y 758.44M
3Y 1.472B
5Y 1.658B
10Y 2.047B
As of April 30, 2017

XBI Risk Info

Beta (5Y) 1.453
Max Drawdown (All) 49.39%
Historical Sharpe (10Y) 0.7077
Historical Sortino (All) 0.9585
30-Day Rolling Volatility 20.13%
Daily Value at Risk (VaR) 1% (All) 4.89%
Monthly Value at Risk (VaR) 1% (All) 21.39%

XBI Fundamentals

Dividend Yield TTM (5-24-17) 0.16%
SEC Yield (5-22-17) 0.04%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 9.170
Weighted Average Price to Book Ratio 5.667
Weighted Median ROE -11.09%
Weighted Median ROA -18.46%
Forecasted Dividend Yield 0.26%
Forecasted PE Ratio 22.38
Forecasted Price to Sales Ratio 4.310
Forecasted Price to Book Ratio 4.617
Number of Holdings 94
As of May 22, 2017

XBI Growth Estimates

Forecasted 5 Yr Earnings Growth 8.15%
Forecasted Book Value Growth 10.53%
Forecasted Cash Flow Growth 23.97%
Forecasted Earnings Growth 25.88%
Forecasted Revenue Growth 24.23%
As of May 22, 2017

XBI Comparables

Edit

XBI Attributes

Key Dates
Inception Date 1/31/2006
Last Annual Report Date 6/30/2016
Last Prospectus Date 10/31/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

XBI Excel Add-In Codes

  • Name: =YCI("XBI","name")
  • Broad Asset Class: =YCI("XBI", "broad_asset_class")
  • Broad Category: =YCI("XBI", "broad_category_group")
  • Prospectus Objective: =YCI("XBI", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

{{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.